This UnitedHealth Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday – Artelo Biosciences (NASDAQ:ARTL), BILL Holdings (NYSE:BILL)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Jefferies analyst Julien Dumoulin-Smith downgraded Sunrun Inc. RUN from Hold to Underperform and lowered the price target from $6 to $5. Sunrun shares closed at $8.86 on Tuesday. See how other analysts view this stock.
Baird analyst Michael Ha downgraded the rating for UnitedHealth Group Incorporated UNH from Outperform to Neutral and lowered the price target from $356 to $312. UnitedHealth shares closed at $303.79 on Tuesday. See how other analysts view this stock.
Goldman Sachs analyst Kash Rangan downgraded GitLab Inc. GTLB from Buy to Neutral and cut the price target from $63 to $50. GitLab shares closed at $48.51 on Tuesday. See how other analysts view this stock.
Morgan Stanley analyst Keith Weiss downgraded BILL Holdings, Inc. BILL from Overweight to Equal-Weight and lowered the price target from $60 to $55. BILL Holdings shares closed at $45.37 on Tuesday. See how other analysts view this stock.
D. Boral Capital analyst Jason Kolbert downgraded the rating for Artelo Biosciences, Inc. ARTL from Buy to Hold. Artelo Biosciences shares closed at $1.13 on Tuesday. See how other analysts view this stock.

Considering buying UNH stock? Here’s what analysts think:

Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.